SERPINB4 and hepatocellular carcinoma: The small number of patients did not allow to identify significant differences between serpinB3-IgM and serpinB4-IgM behaviour, despite cirrhotic patients who developed HCC showed a trend to higher reactivity for all circulating biomarkers.